Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial
2018272 citationsJonathan Strosberg, Edward M. Wolin et al.profile →
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
Countries citing papers authored by David Bushnell
Since
Specialization
Citations
This map shows the geographic impact of David Bushnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bushnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bushnell more than expected).
This network shows the impact of papers produced by David Bushnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bushnell. The network helps show where David Bushnell may publish in the future.
Co-authorship network of co-authors of David Bushnell
This figure shows the co-authorship network connecting the top 25 collaborators of David Bushnell.
A scholar is included among the top collaborators of David Bushnell based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with David Bushnell. David Bushnell is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Strosberg, Jonathan, Edward M. Wolin, Beth Chasen, et al.. (2018). QOL Improvements in NETTER-1 Phase III Trial in Patients With Progressive Midgut Neuroendocrine Tumors. Pancreas. 47(3). 355–355.3 indexed citations
6.
Wolin, Edward M., Beth Chasen, M. Kulke, et al.. (2017). NETTER-1 Phase III Trial : Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors. Neuroendocrinology. 105. 257–257.2 indexed citations
Strosberg, Jonathan, Edward M. Wolin, Beth Chasen, et al.. (2016). NETTER-1 Phase III in Patients With Midgut Neuroendocrine Tumors Treated With 177Lu-DOTATATE: Efficacy and Safety Results.. Neuroendocrinology. 103(5 Suppl 7). 629–629.19 indexed citations
Bushnell, David, et al.. (1991). Comparison of IMP and HMPAO for SPECT Brain Imaging. Journal of Nuclear Medicine Technology. 19(2). 70–74.1 indexed citations
Dai, Hui, et al.. (1989). Recent developments in buckling of structures : presented at the Winter Annual Meeting of the American Society of Mechanical Engineers, San Francisco, California, December 10-15, 1989.1 indexed citations
Bushnell, David, Robert E. Polcyn, & David T. Uehling. (1984). Scintigraphic evaluation of the urinary system in a case of severe renal trauma.. PubMed. 25(9). 1053–5.
18.
Bushnell, David. (1981). Panel Optimization with Integrated Software (POIS). Volume 1: PANDA: Interactive program for preliminary minimum weight design.1 indexed citations
19.
Bushnell, David. (1972). Stress, Stability, and Vibration of Complex Branched Shells of Revolution: Analysis and User's Manual for BOSOR4. Defense Technical Information Center (DTIC).13 indexed citations
20.
Bushnell, David. (1968). NONLINEAR ANALYSIS FOR AXISYMMETRIC ELASTIC STRESSES IN RING-STIFFENED, SEGMENTED SHELLS OF REVOLUTION. Defense Technical Information Center (DTIC).2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.